Your Mounjaro price guide · October 2026
Mounjaro Doesn't Work? Reasons and Next Steps (October 2026)
Mounjaro does not work the same way for everyone, but most apparent failures have a fixable cause: a dose that is still low, too little time on treatment, a normal plateau, or eating habits that have drifted. Trial results are averages, and individual results vary.2 Your prescriber can review your response and decide whether to continue, adjust or stop. Current as of October 2026.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Why progress can feel stuck
Feeling that Mounjaro is not working is common, and it is usually a question of dose, time or habits rather than the medicine failing outright.
- Price includes prescriber assessment and standard delivery — no consultation fees
- Orders approved by 3pm for next-day tracked delivery
- GPhC-registered pharmacy 9012878
- Needles and sharps disposal included
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
Trial results are averages, so some people lose more and some lose less on the same dose.
-
The starting doses are an adjustment phase; most measurable progress builds from 5mg onward.
-
A plateau of a few weeks is normal and is not a reason to double doses or add unlicensed products.
-
Your prescriber reviews response after 6 months on the highest dose you can tolerate and can adjust or stop.
-
Still hungry or not losing? Check dose, time, food intake, protein, sleep and alcohol before assuming failure.
In this guide
01 · The core answer
Is Mounjaro really not working, or is it too early to tell?
Mounjaro can fail to deliver the result you hoped for, but before concluding that, it is worth separating three situations: you are early in treatment, you have hit a plateau, or you have been on a suitable dose for long enough with little change. Each has a different next step, and only the last one points towards a genuine poor response.
Weight loss on this medicine is slow by design. The first weeks on 2.5mg are an adjustment phase and losses are usually modest. Most measurable progress builds from 5mg onward, month by month.1 If you are in that early phase, the dose that helps you most may simply still be ahead of you.
If you have been taking it for longer, the question becomes what has changed. Portions can creep back up, protein and activity can slip, sleep and alcohol can quietly undo a calorie deficit. Mounjaro supports a reduced-calorie diet; it does not replace one. Treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.2
02 · What to do next
The decisions you are actually facing
Most readers land on one of two decisions. The first is whether to wait: if you are still in the early dose steps, or you have only plateaued for a few weeks, patience and a food review are usually the right move.
The second is whether to ask for a clinical review. If you have been on the highest dose you can tolerate for a sustained period and the scales have barely moved, talk to your prescriber. The review point is clear: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.4 Never double doses or add unlicensed products yourself.
Already treated with us? Ongoing monthly reviews, dose titration and follow-up assessments by the prescribing team are part of the service. For wider support, see our weight loss clinic page.
Whatever you decide, judge progress by trend rather than by individual weigh-ins. A single flat week tells you very little, and a pattern across several weeks tells you much more.
03 · Does it work for everyone
Is it possible that Mounjaro doesn't work for you?
Yes, it is possible, because no medicine works identically for every person. Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes, and it is used alongside a reduced-calorie diet and increased physical activity.1 What the research shows are averages across large groups, and averages hide a wide spread of individual outcomes. Our page on whether it works for everyone covers this question head on.
The headline trial for weight management makes the point well. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2 The key phrase is "on average". Some participants did better than those figures, and some did worse.
That variation is why we avoid promising any outcome. These are trial averages, and they do not predict your own result. Your age, starting weight, other medicines, medical conditions, sleep, stress and food environment all shape how you respond. None of that means the medicine is broken; it means the response is personal.
What "not working" can mean
People use the phrase to describe quite different experiences. Some mean the scales have not moved. Some mean their appetite has not changed. Others mean they lost weight at first and then stopped. Each of these has a different explanation, which is why it helps to name exactly what you are seeing before deciding what to do.
If appetite has not changed, the mechanism is worth revisiting. Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1, which help regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin.1 In practice, most people feel fuller sooner and less hungry between meals. Most is not all, and the effect can be gentle at lower doses.
If the scales have not moved but your clothes fit differently, or your measurements are changing, that is still a response. The trial data also describe average improvements in waist size, blood pressure, cholesterol and blood-sugar measures alongside weight loss, though these are trial-average secondary outcomes, not promises.2 A single number on a bathroom scale is only one view of what is happening.
Is true non-response possible?
Some people will respond poorly even at a suitable dose given enough time. That is a medical judgement for your prescriber, not something to decide from a few flat weeks. The sensible route is to rule out the common, fixable causes first, then ask for a structured review.
It is also worth being wary of confident claims online that a medicine either always works or never works. Both are wrong. The accurate position is that response varies, most people benefit within the licensed approach, and a minority need their plan changed. Knowing which group you are in takes honest data and clinical input, not guesswork.
04 · Dose still too low
Why a low dose may explain slow progress
A dose that is still low is one of the most common reasons Mounjaro seems not to work. The pen comes in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.1 Treatment starts at the bottom of that ladder on purpose, and the first strength is not designed to deliver the full effect.
The first weeks on 2.5mg are an adjustment phase and losses are usually modest. Most measurable progress builds from 5mg onward, month by month.4 Some people notice an appetite change in the first week; others feel little until a higher dose. Both are normal. If you have judged the medicine on its starting strength alone, you have judged it before it has really begun.
How the dose scales
The trial figures follow the same pattern. Average losses at the 72-week mark were higher on 10mg than on 5mg, and higher again on 15mg.2 That does not mean everyone needs the top dose. Many people settle on a middle strength that works well for them with manageable side effects. The right maintenance dose is the one that gives you a steady response you can tolerate, as agreed with your prescriber.
Why your prescriber controls the step-ups
Dose increases are made by the prescriber, not by the patient. Within the licence, one response to a plateau is to discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.4 Titration moves up after at least 4 weeks on each dose, depending on how you respond and tolerate it.
Moving up too fast can bring more nausea and other side effects, which is why the steps are paced. If you are tempted to rush, remember that a higher dose that you cannot tolerate is not more effective in practice if it makes you stop. Equally, staying on a dose that is too low out of caution can leave you under-treated.
What not to do
Doubling doses or adding unlicensed products is not safe and is not supported by any UK regulator. If you feel the dose is not enough, say so at your review and let the prescriber decide.
If you are on a mid-range dose and wondering what the next strength would add, bring your questions, side-effect history and food diary to your next review so the decision rests on facts.
05 · Time and pace
Have you given it enough time?
Often the honest answer is not yet. Weight loss on Mounjaro is gradual by design. The trials measured results at 72 weeks, and the sensible way to think about progress is in months, not days. If you are comparing yourself with dramatic stories online, you are probably comparing your early weeks with someone else's later ones.
Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures: in SURMOUNT-1, average weight loss built month by month, with the full 15–21% averages measured at 72 weeks, not 12.2 A sensible expectation at that point is mid single digits as a percentage of body weight, with wide individual variation. Slower early progress does not predict failure — the dose you respond to may still be ahead of you.
Why early weeks mislead
Early loss includes water weight, so the trend over weeks matters more than any single weigh-in. Some people drop quickly at the start and then slow; others see almost nothing and then move steadily. Neither pattern tells you much on its own.
Early side effects can also colour how you feel. Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.4 If you feel unwell and eat very little one week, then eat more the next, your weight will bounce around for reasons unrelated to how well the medicine is working.
How to track fairly
Weigh at the same time of day, on the same scale, under similar conditions, and look at the direction over several weeks. Take measurements around the waist, note how clothes fit and record your appetite and portion sizes. A free companion app such as GLPTrackr can help you keep a simple record of doses, weight and symptoms in one place.
Also remember what the scales cannot show. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.2 These are trial averages, not promises, but they are why prescribers talk about weight management as health management rather than appearance. Ask your prescriber which of these markers are worth checking in your own case.
The formal review point
There is a defined checkpoint. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.4 Note the wording: it refers to the highest tolerated dose, not to any dose, and not to the first few weeks. If you have not reached that point, the fair conclusion is usually that the verdict is still open.
06 · Plateaus
When weight loss stalls on Mounjaro
A stall does not mean Mounjaro has stopped working. Weight loss on Mounjaro is not linear — plateaus of a few weeks are normal and expected as the body adapts to a lower weight.4 The body defends its weight, and as you lose, daily energy needs fall. A plateau is often the point where the same eating pattern that produced a loss now only maintains it.
The within-licence checklist
The responses within the licence are practical and unglamorous. First, review food intake honestly, because portions drift back up without anyone noticing. Second, protect protein and activity, since both help you keep muscle and stay full. Third, check the basics, such as sleep and alcohol. Fourth, discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.4
Let us take each in turn. Food intake: write down what you eat for a typical stretch, including snacks, sauces, drinks and weekend meals. Many people are surprised by what the diary shows. You do not need to be perfect; you need to be accurate. Because the medicine slows how quickly the stomach empties, smaller meals feel adequate, but calorie-dense foods and liquid calories can still add up.
Protein and activity: if appetite is low, protein is often the first thing to slip. Building it into each meal, and keeping up walking or resistance work you enjoy, supports the whole plan. Sleep and alcohol: poor sleep tends to raise appetite and make cravings harder to manage, and alcohol adds calories while lowering restraint. Neither is a moral failing; both are levers you can pull.
What a plateau is not
A plateau is not a reason to double doses or add unlicensed products.4 They carry real risks and have no place in a licensed treatment plan. If someone offers to supply a stronger or cheaper alternative without a consultation or prescription, walk away.
When to escalate
If the stall has gone on for a sustained period despite an honest review of habits, book a review. Bring your weight trend, dose history, food and sleep notes and any side effects. Your prescriber can judge whether the cause is behavioural, dose-related or something that needs a different approach. If you are not at the top strength, a step-up may be the logical move; if you are at the maximum you tolerate, the conversation shifts to continuing, adjusting or stopping.
Our broader discussion of why results differ between people explains why two people on the same dose can follow very different curves, and why comparing yourself with others is rarely useful.
Finally, remember that maintaining a lower weight is itself a success. A flat line after a period of loss can reflect the body reaching a new balance, which is worth recognising rather than fighting at every step.
07 · Still hungry
Why you can still feel hungry on Mounjaro
Feeling hungry on Mounjaro, even on a higher dose, does not automatically mean it has failed. The medicine works by activating GIP and GLP-1 receptors, which help regulate appetite and slow how quickly the stomach empties. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.1
Hunger versus appetite
It helps to separate physical hunger from habit, emotion and environment. The medicine acts on the biology of fullness. It does not remove the pleasure of food, the pull of routine snacking or the comfort of eating when stressed. People sometimes notice that physical hunger drops while cravings tied to mood or cues persist. Recognising which one you are feeling is a useful first step.
If you are still hungry on a mid-range dose, there are practical things to check. Are meals built around protein and fibre-rich foods that keep you satisfied? Are you eating at regular times, or skipping meals and then overeating later? Are you drinking enough water? Is poor sleep making appetite louder? These are lifestyle questions, but they interact directly with how well the medicine works for you.
Timing across the week
Many people notice the effect is stronger in the days after the injection and fades towards the end of the week. Mild nausea, altered appetite and tiredness in the first days after each injection are among the commonest early effects.4 If your hunger returns noticeably before the next dose, tell your prescriber. They can talk through pacing of meals, dose and whether the pattern is expected.
When it points to a dose conversation
If hunger remains strong and your weight has stalled, the dose may be insufficient for you. That is exactly the situation in which to discuss a step-up if you are not yet at maximum.4 If you are already at a higher strength and tolerating it, the review can look at whether anything else is driving appetite, including sleep, other medicines and medical conditions.
Do not respond to hunger by adding over-the-counter appetite products. Low-cost supplements sold with dramatic weight-loss claims come with no clinical oversight and no standardised dosing, and some can interact with prescribed treatment. If appetite is a problem, a prescriber conversation is safer and more useful.
For a wider look at the question of who responds and who does not, our page on whether GLP-1 medicines work for everyone sets out the general picture across this medicine class, and why individual appetite responses differ so widely.
08 · Practical checks
Practical checks before you blame the medicine
Before concluding that Mounjaro has failed, run through the practical basics. They are dull, but they catch more problems than people expect, and they are all things you can check today without changing your treatment.
Technique and routine
Follow the pen's instructions each time, and use the needles, sharps bin and injection guidance provided with your order. If you are unsure whether a dose was delivered properly, do not repeat it on your own. Contact the pharmacy or your prescriber and describe exactly what happened. If you miss a dose, take it as soon as you can within 4 days (96 hours) of the scheduled time; if more than 4 days have passed, skip it and take the next one on your normal day — never take two doses within 3 days of each other.13
Keep a consistent injection day, record each dose and note any missed ones. Gaps in the schedule affect how steadily the medicine works, and they also change how side effects feel when you restart. A simple log, on paper or in an app, makes your review far more productive.
Storage
Pens should be stored in the fridge between 2–8°C until first use, and unopened pens keep until the printed expiry date. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away. Do not use a pen that has been above 30°C or has been frozen. If you are unsure whether a pen has been stored properly, check the patient information leaflet and ask the pharmacy rather than guessing.13 We deliver in discreet, temperature-controlled packaging to protect the pens in transit.
Other medicines and conditions
Tell your prescriber about everything else you take. If you use insulin or sulfonylureas, doses may need adjusting because of the risk of low blood sugar. Because the medicine slows stomach emptying, it can reduce how well oral contraceptive pills are absorbed.1 The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.1 Other medicines and health conditions can influence weight and appetite too, which is another reason a clinical review is more reliable than guesswork.
Side effects that undermine progress
Persistent nausea or discomfort can lead people to eat in ways that backfire, such as small frequent snacks of bland, calorie-dense foods. If side effects are getting in the way, say so. You can also report suspected side effects through the Yellow Card scheme.19 If you notice any new or lasting symptom, tell your prescriber. For severe, persistent stomach pain, swelling of the face, lips, tongue or throat, or difficulty breathing, get medical help straight away.
Where the pen came from
Only a regulated pharmacy supplying genuine pens gives you reliable treatment. Our Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, and every order is reviewed by a GPhC-registered prescriber. Anyone offering pens without a consultation or prescription is a warning sign, because a counterfeit or mishandled pen could explain a poor response and may be dangerous.
09 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1
10 · Review and next steps
What your prescriber can do if progress is poor
If you have worked through the basics and progress is still poor, the next step is a structured review with your prescriber. This is the safe, licensed route, and it is much more likely to help than trying to fix the problem alone.
What the review looks at
A good review covers your dose history, how long you have been on each strength, side effects, eating pattern, activity, sleep, alcohol and other medicines. It also looks at what you hoped for. If expectations were set by dramatic online stories rather than trial averages, part of the conversation may be recalibrating what a good result looks like for you.
The formal checkpoint is clear. If you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.4 Adjusting could mean a dose change, a different pacing of increases or additional support with diet and activity. Stopping is a legitimate outcome if the benefit does not justify continuing.
If you stop
If you decide to stop, be aware that tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.1 Plan the transition with your prescriber so that your eating habits are supported once appetite effects wear off. Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.14
Other licensed options
Mounjaro is not the only licensed weight-management treatment. Semaglutide, sold as Wegovy, is another once-weekly injection, with pens of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg; the dose steps up after 4 weeks on each of 0.25mg, 0.5mg, 1mg and 1.7mg, so the 2.4mg maintenance dose starts from week 17.18 Whether a switch makes sense is a clinical decision for you and your prescriber, based on your history rather than on headlines. Do not assume a different medicine will behave differently without that discussion. Our overview of whether weight loss injections work for everyone frames how response varies across the whole class.
NHS and private routes
Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).46 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.
How to get a review with us
If you are already a customer, ongoing monthly reviews, dose titration and follow-up assessments are part of the service, and repeat orders re-check suitability with no auto-shipping. If you are new, the consultation is free, short and reviewed by a GPhC-registered prescriber, and unsuitable orders are refunded automatically. The right treatment plan is the one that is reviewed, adjusted and honest about what is working.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamWhy is Mounjaro not working for me?
Does Mounjaro work for everyone?
Are some people resistant to Mounjaro?
How can I make Mounjaro work better?
Why am I still hungry on Mounjaro 10mg?
How long should I give Mounjaro before deciding it isn't working?
Is a plateau on Mounjaro normal?
What happens if I stop Mounjaro because it isn't working?
Should I switch medicine if Mounjaro isn't working?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 7 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- Wegovy — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC)
- MHRA Yellow Card scheme — report a side effect
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


